Hicomp Microtech

About Hicomp Microtech

Hicomp Microtech, established in 2014, operates as an original design manufacturer (ODM) focused on the microfluidics and life sciences laboratory consumables sectors. The company was founded by Dr. Jing Chen, who brings 28 years of expertise in Microfluidics, MEMS, and Manufacturing Engineering. His background includes a PhD from Tsinghua University, research at the University of Michigan, and a 16-year tenure as a professor at Peking University, culminating in a portfolio of over 180 papers and 70 patents.

The firm provides end-to-end services, from initial concept design and prototyping to high-volume, cleanroom mass production of customized microfluidic chips and lab consumables. Its business model centers on contract manufacturing and OEM services for a global client base that includes over 1,000 research groups and biotech companies. Hicomp serves entities in immunodiagnosis, biochemical diagnosis, and blood testing by transforming client designs into functional products. The company operates a more than 100,000-square-foot facility, which includes 40,000 square feet of cleanroom space, and has delivered on over 500 projects across diagnostics and life sciences.

Hicomp's core offerings encompass the design, processing, and manufacturing of micro-nano components using materials like polymers (PDMS, PC, PMMA), glass, silicon, and ceramics. The company has developed proprietary technologies for producing components with microfeatures as small as 10 micrometers. Its product applications are extensive, supporting organ-on-a-chip systems, droplet microfluidics, single-cell analysis, liquid biopsies, and drug screening. The company also offers a complete line of laboratory consumables, such as pipette tips, cell culture equipment, and PCR products. A key milestone was securing 100 million yuan ($13.9 million) in a Series B+ financing round in October 2022, led by Shunwei Capital, to expand production and research.